Big Move For AVITA Medical, Inc.
AVITA Medical, Inc. (RCEL:NASDAQ) jumped higher at $7.77, representing a gain of 63.6%. On Fri, Aug 07, 2026, RCEL:NASDAQ hit a New 2-Week High of $7.77. The stock appeared on our News Catalysts scanner on Fri, Aug 07, 2026 at 11:32 AM in the 'MISCELLANEOUS' category. From Fri, Jul 24, 2026, the stock recorded 60.00% Up Days and 45.45% Green Days
About AVITA Medical, Inc. (RCEL:NASDAQ)
Avita Medical is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. In addition to its ASX listing, Avita listed on the Nasdaq in November 2019.
Top 10 Gainers:
- Yunji Inc. (YJ:NASDAQ), 149.69%
- Westwater Resources, Inc. (WWR:NYSEMKT), 87.76%
- AVITA Medical, Inc. (RCEL:NASDAQ), 63.58%
- Jinxin Technology Holding Company (NAMI:NASDAQ), 51.92%
- Healthy Choice Wellness Corp. (HCWC:NYSEMKT), 50%
- Movella Holdings Inc. (MVLA:NASDAQ), 50%
- VivoSim Labs, Inc. (VIVS:NASDAQ), 41.86%
- QuinStreet, Inc. (QNST:NASDAQ), 38.5%
- OmniAb, Inc. (OABI:NASDAQ), 37.5%
- Huize Holding Limited (HUIZ:NASDAQ), 37.18%